LOCALLY ADVANCED SOLID TUMOR
Clinical trials for LOCALLY ADVANCED SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED SOLID TUMOR trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cancer combo trial halted early
Disease control TerminatedThis study tested a new drug called OC-001, either by itself or combined with avelumab (an immunotherapy), in people with advanced cancers that had spread. The goal was to check safety and how the drug moves through the body. The trial was stopped early, and only 73 people were e…
Matched conditions: LOCALLY ADVANCED SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Ocellaris Pharma, Inc. • Aim: Disease control
Last updated May 26, 2026 03:12 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested an experimental drug called TransCon TLR7/8 Agonist, alone or with another drug (pembrolizumab), in people with advanced solid tumors that had stopped responding to standard treatments. The goal was to find a safe dose and check for side effects. The trial was t…
Matched conditions: LOCALLY ADVANCED SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Ascendis Pharma Oncology Division A/S • Aim: Disease control
Last updated May 26, 2026 03:06 UTC
-
Targeted drug shows promise for rare genetic cancers
Disease control TerminatedThis study tested the drug niraparib in 22 adults with advanced solid tumors (like breast, lung, or pancreatic cancer) that have a specific genetic change called a PALB2 mutation. The goal was to see if niraparib could shrink tumors or slow their growth. The study was stopped ear…
Matched conditions: LOCALLY ADVANCED SOLID TUMOR
Phase: PHASE2 • Sponsor: Tempus AI • Aim: Disease control
Last updated May 26, 2026 02:47 UTC
-
Cancer drug trial halted: new hope for Gene-Deficient tumors?
Disease control TerminatedThis study tested an experimental oral drug called TNG908 in adults with advanced solid tumors that lack the MTAP gene. The goal was to find a safe dose and see if the drug could shrink tumors. The trial was stopped early, but results may still inform future treatments for these …
Matched conditions: LOCALLY ADVANCED SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Tango Therapeutics, Inc. • Aim: Disease control
Last updated May 19, 2026 11:47 UTC